浙江天正电气股份有限公司 2025 年第三季度报告 证券代码：605066 证券简称：天正电气 浙江天正电气股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 比上年同 | 年初至报告期末 | 末比上年同期 | | | | 期增减变 | | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 715,430,811.34 | 6.69 | 2,169,930 ...

Financial Performance - The company's operating revenue for the third quarter was ¥74,463,133.35, a decrease of 23.60% compared to the same period last year[4] - The total profit for the quarter was -¥11,136,712.35, with a year-to-date total profit of -¥45,411,967.10[4] - The net profit attributable to shareholders was -¥8,059,027.95 for the quarter, and -¥34,988,266.56 year-to-date[4] - The basic earnings per share for the quarter was -¥0.02, and -¥0.10 year-to-date[5] - Net profit for the first three quarters of 2025 was a loss of CNY 47,739,528.36, compared to a loss of CNY 31,527,163.24 in the same period of 2024, representing a decline of 51.5%[22] - The company reported a basic and diluted earnings per share of CNY -0.10, compared to CNY -0.07 in the previous year[23] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,330,178,736.43, a decrease of 7.30% from the end of the previous year[5] - Total assets as of September 30, 2025, are ¥1,330,178,736.43, down from ¥1,434,868,405.00 at the end of 2024[16] - Total liabilities decreased to ¥374,319,216.99 from ¥431,269,357.20 year-over-year[17] - Total liabilities and equity amounted to CNY 1,330,178,736.43, a decrease from CNY 1,434,868,405.00 in the previous year[18] - The equity attributable to shareholders was ¥907,957,615.90, down 3.71% from the previous year-end[5] - The equity attributable to shareholders of the parent company was CNY 907,957,615.90, down from CNY 942,945,882.46 year-over-year[18] Cash Flow - The company reported an increase in cash flow from operating activities, primarily due to increased cash received from sales[9] - Cash flow from operating activities showed a net outflow of CNY 2,549,106.40, an improvement from a net outflow of CNY 39,739,381.65 in the previous year[25] - Cash inflow from investment activities was CNY 546,174,611.33, compared to CNY 485,264,285.65 in the same period of 2024, indicating a growth of 12.6%[25] - Cash outflow for investment activities totaled CNY 535,605,489.14, an increase from CNY 507,416,819.37 year-over-year[25] - The net cash flow from financing activities was -$3,502,142.91, a significant decrease compared to $26,412,579.47 in the previous period[26] - The total cash and cash equivalents at the end of the period increased to $85,569,044.99 from $64,093,737.35, reflecting a net increase of $4,517,872.88[26] - The cash outflow from financing activities totaled $5,647,670.03, compared to $3,397,100.80 in the previous period[26] Shareholder Information - The total number of common shareholders at the end of the reporting period is 10,899[12] - The largest shareholder, Anji Yiqing Technology Partnership, holds 88,872,943 shares, representing 25.00% of total shares[12] - The company has no significant changes in the top 10 shareholders or their shareholding status compared to the previous period[13] Operational Insights - The overall production costs remained high, impacting the gross profit margin negatively[9] - The company is focusing on improving operational efficiency to mitigate the impact of high fixed costs on profitability[10] - There are no new strategies or significant operational changes reported for the current period[14] Research and Development - Research and development expenses decreased to CNY 8,814,595.04, down 28.5% from CNY 12,254,545.11 year-over-year[21]

Financial Performance - The company's operating revenue for Q3 2025 reached ¥508,156,758.74, an increase of 5.81% compared to the same period last year[3] - Net profit attributable to shareholders was ¥11,691,688.54, reflecting a growth of 14.43% year-on-year[3] - The net profit excluding non-recurring gains and losses was ¥7,431,590.26, up 6.03% from the previous year[3] - Total operating revenue for the current period reached ¥1,414,516,724.97, an increase of 9.9% compared to ¥1,287,401,829.56 in the previous period[16] - Total operating costs amounted to ¥1,407,834,325.66, up from ¥1,270,797,082.91, reflecting a growth of 10.8%[16] - Net profit for the current period was ¥30,211,598.35, slightly down from ¥30,335,190.46, indicating a decrease of 0.4%[17] - Earnings per share (EPS) increased to ¥0.114 from ¥0.099, representing a growth of 15.2%[18] - The company reported a total comprehensive income of ¥28,024,734.11, down from ¥31,080,686.11, a decrease of 9.9%[18] - Investment income for the current period was ¥6,754,697.36, compared to ¥6,352,068.06, reflecting an increase of 6.3%[17] Cash Flow - The cash flow from operating activities for the year-to-date was ¥95,885,061.89, up 15.49% year-on-year[3] - Cash flow from operating activities generated a net amount of ¥95,885,061.89, compared to ¥83,024,620.91 in the previous period, marking an increase of 15.1%[19] - Net cash flow from investment activities was -137,439,200.14, compared to -382,079,025.20 in the previous period, indicating an improvement[20] - Cash inflow from financing activities totaled 979,536,056.64, up from 703,247,873.97, reflecting increased borrowing[20] - Cash outflow for debt repayment was 889,235,733.98, significantly higher than 260,057,857.61 in the prior period[20] - The net increase in cash and cash equivalents was 85,468.55, compared to 76,060,039.33 previously, showing a modest increase[20] - The ending balance of cash and cash equivalents was 245,829,249.94, compared to 223,231,564.43 in the previous period[20] - Total cash outflow from investment activities was 963,440,052.80, compared to 681,658,161.80 previously, indicating increased investment spending[20] - Cash flow from financing activities netted 41,675,044.34, a decrease from 374,214,867.64 in the prior period[20] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥3,856,493,161.49, representing a 2.15% increase from the end of the previous year[3] - The company's total current assets amount to ¥1,976,762,052.39, an increase from ¥1,909,759,015.71 at the beginning of the period[12] - The total liabilities of the company are ¥2,838,097,731.55, with current liabilities at ¥1,383,891,121.17[13] - Total liabilities increased to ¥1,984,520,939.64 from ¥1,929,482,124.17, a rise of 2.9%[14] - The company's cash and cash equivalents increased to ¥266,456,779.55 from ¥252,431,912.37[12] - Inventory levels rose to ¥698,892,704.07, up from ¥649,214,003.34[12] - The company has a total of ¥124,989,918.51 in accounts payable, an increase from ¥81,763,799.58[13] - The company’s long-term borrowings stand at ¥454,206,610.38, down from ¥472,826,452.02[13] - The company's total equity attributable to shareholders reached ¥1,802,995,537.20, compared to ¥1,777,137,438.47, an increase of 1.4%[14] Shareholder Information - The total number of common shareholders at the end of the reporting period is 31,496[10] - The largest shareholder, Shenzhen Yinqiao Investment Co., Ltd., holds 13.92% of shares, totaling 36,635,001 shares[10] Other Information - The company experienced a 64.03% decrease in net cash flow from investing activities, totaling -¥137,440,000, mainly due to reduced capital expenditures for base construction[9] - The net cash flow from financing activities decreased by 88.86% to ¥41,680,000, primarily due to increased cash outflows for repaying bank loans[9] - The company did not undergo an audit for the third quarter financial report[21] - The new accounting standards will be first implemented starting in 2025[22]

南京医药股份有限公司2025 年第三季度报告 证券代码：600713 证券简称：南京医药 债券代码：110098 债券简称：南药转债 （一） 主要会计数据和财务指标 南京医药股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 第三季度财务报表是否经审计 □是√否 一、主要财务数据 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期比上 | 年初至报告期末 | 年初至报告 | | --- | --- | --- | --- | --- | | | | 年同期增减变 | | 期末比上年 | 1 / 16 南京医药股份有限公司2025 年第三季度报告 | | | 动幅度(%) | | 同期增减变 | | | --- | ...

Financial Performance - The company's operating revenue for Q3 2025 was ¥241,559,161.11, a decrease of 14.38% year-on-year, while the revenue for the year-to-date period was ¥732,722,538.76, down 4.11% compared to the same period last year[5] - Net profit attributable to shareholders for Q3 2025 was ¥27,748,294.53, an increase of 29.45% year-on-year, and the year-to-date net profit was ¥94,274,126.29, up 25.75%[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2025 was ¥26,646,913.92, a growth of 35.28% year-on-year, with a year-to-date figure of ¥92,694,170.99, increasing by 44.38%[5] - The basic earnings per share for Q3 2025 was ¥0.12, reflecting a 20.00% increase year-on-year, while the diluted earnings per share was also ¥0.12, with the same growth rate[5] - The company's net profit for the current period is 93,381,165.17, an increase of 24.6% compared to 74,871,253.18 in the previous period[21] - Operating profit for the current period is 101,826,062.84, up from 81,710,704.18, reflecting a growth of 24.6%[21] - The total profit for the current period is 101,848,915.38, compared to 81,675,963.03 in the previous period, reflecting a growth of 24.6%[21] Assets and Liabilities - Total assets at the end of Q3 2025 amounted to ¥2,023,718,971.66, representing a 0.75% increase from the end of the previous year[5] - Total assets increased slightly to ¥2,023,718,971.66 from ¥2,008,712,602.76, representing a growth of 0.7%[19] - Total liabilities decreased to ¥563,081,654.38 from ¥587,184,960.66, a reduction of 4.1%[18] - The company's equity attributable to shareholders rose to ¥1,371,530,278.40 from ¥1,330,748,271.90, an increase of 3.1%[19] Cash Flow - The company's cash flow from operating activities for the year-to-date period reached ¥216,842,645.22, a significant increase of 326.06%[5] - Cash flow from operating activities has significantly improved, with a net cash flow of 216,842,645.22 compared to a negative cash flow of -95,922,978.51 in the previous period[22] - The net cash flow from investing activities was -181,769,603.65, a decline from a positive cash flow of 148,077,336.06 in the previous period[22] - The company experienced a net cash outflow from financing activities of -58,371,592.37, slightly improved from -60,894,415.63 in the previous period[23] Revenue and Costs - Sales revenue reached ¥1,015,987,802.56, reflecting a growth of 61.31% primarily due to the collection of overdue payments[11] - Total operating revenue for the current period was ¥732,722,538.76, a decrease of 4.9% from ¥764,126,725.89 in the previous period[20] - Total operating costs decreased to ¥641,528,075.06, down 7.9% from ¥696,500,217.93 in the previous period[20] - Operating costs included ¥556,920,034.65 for cost of goods sold, a reduction from ¥611,927,565.87, indicating a 9% decrease[20] - The company reported a net profit margin improvement, with net profit increasing despite lower revenues, reflecting effective cost management[20] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 21,326, with no preferred shareholders[13] - The largest shareholder, Peng You, holds 55.14% of the shares, totaling 123,201,488 shares[13] Investments and Assets - The company invested ¥95,343,957.15 in fixed assets, an increase of 49.01% due to the acquisition of new equipment[11] - The company's fixed assets increased by 70.70% to ¥406,343,997.59, mainly due to the transfer of construction projects to fixed assets[10] - The company recorded a significant increase of 686.09% in other non-current assets, amounting to ¥17,855,892.14, attributed to an increase in prepaid equipment[10] Research and Development - Research and development expenses remained stable at ¥39,477,815.75, slightly up from ¥39,399,324.22, indicating continued investment in innovation[20] - The company plans to expand its market presence and invest in new technologies to drive future growth[20] Other Financial Metrics - The company incurred an impairment loss of ¥9,318,362.95, which is an increase of 91.93% attributed to higher inventory write-downs[11] - Cash received from investment income decreased by 53.43% to ¥6,206,471.57, primarily due to a decline in the yield of financial products[11] - Cash and cash equivalents decreased to ¥128,057,621.15 from ¥152,262,500.64, a decline of 15.9%[18] - Cash and cash equivalents at the end of the period totaled 116,120,646.91, compared to 28,531,036.44 at the end of the previous period, showing a significant increase[23] - Cash received from financing activities increased by 93.36% to ¥8,097,496.00, mainly due to equity incentive impacts[11] Audit Information - The company has not undergone an audit for the third quarter financial report[24]

华联控股股份有限公司 2025 年第三季度报告 证券代码：000036 证券简称：华联控股 公告编号：2025-061 华联控股股份有限公司 2025 年第三季度报告 2 华联控股股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | --- | | | | 增减 | | | 年同期增减 | | 营业收入（元） | 110,537,612.73 | | -3.47 ...

浙江网盛生意宝股份有限公司 2025 年第三季度报告 证券代码：002095 证券简称：生 意 宝 公告编号：2025-035 浙江网盛生意宝股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1 浙江网盛生意宝股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 104,370,337.88 | -22.10% | 410,564,154.17 | 8.69% | | 归属于上市公司股东 | 4,235,339.49 | 135.88% | -2,807,681.87 | 81.11% | | 的净利润（元） | | | | | | 归属于上市公司股东 | | | | | | 的扣除非经常性损益 | 955 ...

证券代码：002030 证券简称：达安基因 公告编号：2025-054 广州达安基因股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述 或重大遗漏，并承担个别和连带的法律责任。 广州达安基因股份有限公司 2025 年第三季度报告 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务 信息的真实、准确、完整。 3.第三季度财务会计报告是否经过审计 □是 否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 164,932,902.94 | -13.50% | 503,506,935.73 | -14.81% | | 归 ...

深圳市宝明科技股份有限公司 2025 年第三季度报告 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 3.第三季度财务会计报告是否经过审计 证券代码：002992 证券简称：宝明科技 公告编号：2025-048 深圳市宝明科技股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 □是 ☑否 1 深圳市宝明科技股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 ☑否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 337,904,553.25 | - ...

Financial Performance - The company's operating revenue for Q3 2025 was CNY 1,716,528,851.64, representing a 6.88% increase compared to CNY 1,606,077,665.38 in the same period last year[5] - Net profit attributable to shareholders was CNY 162,299,987.47, a 13.54% increase from CNY 142,940,624.00 year-on-year[5] - Basic earnings per share for Q3 2025 were CNY 0.16, a 6.67% increase from CNY 0.15 in the same quarter last year[5] - The company reported a significant increase in prepayments to CNY 287,546,903.16 from CNY 133,506,302.99, representing a growth of approximately 115.00%[14] - Total operating revenue for the current period is ¥4,834,976,275.63, a decrease of 2.45% from ¥4,956,233,573.64 in the previous period[17] - Net profit for the current period is ¥488,069,735.53, a decrease of 3.77% compared to ¥507,012,207.07 in the previous period[18] - Earnings attributable to shareholders of the parent company decreased to ¥428,105,874.49, down 9.65% from ¥473,986,269.92[18] - Basic and diluted earnings per share are both ¥0.43, down from ¥0.49 in the previous period[18] Cash Flow - The net cash flow from operating activities for the year-to-date period was CNY 25,126,550.38, showing a significant improvement of 132.20% compared to a negative cash flow of CNY -78,044,100.00 in the previous year[5] - Cash inflow from operating activities increased to ¥5,008,343,797.45, up from ¥4,693,981,222.17[19] - Cash flow from operating activities net amount was $25.13 million, a significant improvement from a negative $78.04 million in the previous period[20] - Cash inflow from financing activities totaled $704.64 million, up from $490.85 million, representing a 43.6% increase[20] - Cash flow from financing activities net amount was $39.22 million, recovering from a negative $100.33 million in the previous period[20] Assets and Liabilities - Total assets at the end of the reporting period were CNY 12,535,923,201.22, reflecting a 5.65% increase from CNY 11,865,695,815.86 at the end of the previous year[5] - The company's equity attributable to shareholders increased by 5.75% to CNY 6,146,297,204.65 from CNY 5,811,898,795.23 at the end of the previous year[5] - Total liabilities rose to CNY 6,014,570,716.06 from CNY 5,655,853,500.14, reflecting an increase of about 6.36%[15] - Owner's equity increased to CNY 6,521,352,485.16 from CNY 6,209,842,315.72, indicating a growth of approximately 5.00%[15] - Total assets and equity increased to ¥12,535,923,201.22 and ¥6,521,352,485.16 respectively, compared to ¥11,865,695,815.86 and ¥6,209,842,315.72 in the previous period[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 41,457[10] - The top three shareholders held a combined 37.09% of the company's shares, with Yantai Guofeng Investment Holding Group Co., Ltd. holding 14.50%[10] Inventory and Receivables - Current assets rose to CNY 8,713,944,224.14, up from CNY 7,941,776,920.55, indicating an increase of about 9.71%[14] - Inventory increased significantly to CNY 1,840,822,506.84 from CNY 1,450,823,561.96, representing a growth of approximately 26.83%[14] - Accounts receivable increased to CNY 1,950,739,199.57 from CNY 1,929,435,357.23, showing a slight increase of about 1.10%[14] Financial Expenses and Other Income - The company reported a financial expense of -¥5,085,651.90, a significant improvement from ¥9,621,362.55 in the previous period[17] - Other comprehensive income after tax for the current period is -¥56,414,946.72, compared to ¥15,361,277.36 in the previous period[18]